A 76-year-old man with permanent non-valvular atrial fibrillation, hypertension and type 2 diabetes presents for review. He has no prior stroke or transient ischaemic attack, no heart failure, and no significant valvular disease on echocardiogram. His CHA₂DS₂-VASc score is 3. What is the most appropriate antithrombotic strategy?